Dr. Weigert UK Ltd is a wholly owned subsidiary of Dr. Weigert GmbH & Co. KG with its manufacturing facilities and European head quarters based within Hamburg, Germany.
Established for over 30 years, Dr. Weigert is at the forefront of advanced chemical decontamination technology. Innovation, research and application excellence within the healthcare and food hygiene industries have ensure Dr. Weigert's position as the market leader.
Effective cleaning is the most important part of the decontamination process. Dr. Weigert's process of cleaning, disinfection and sterilisation 'removes and destroys', thereby preventing micro-organisms from being transmitted through the reprocessing of medical devices. Increasing awareness of Creutzfeldt-Jakob disease and the theoretical challenges of prion transmission - demand only effective, documented and validated processes that will ensure greater safety, and therefore reduce the risk of cross infection.
Dr. Weigert's Neodisher technology has made significant contributions to instrument and endoscope reprocessing, as well as laboratory cleaning both manual and automated. It provides flexible, residue-free solutions with complete material compatibility, whether stainless steel, titanium, aluminium or anodised surface finishes. Our extensive portfolio consist of alkaline and enzymatic cleaners, disinfectants, dual cleaners and disinfectants with broad microbiological effectiveness, including prion deactivation.
Dr. Weigert is also recognized as a leading force within dosing technology. Our Hamburg technicians design, manufacture, install and maintain, both simple single dosing units, and central dosing systems that feed multiple washer / disinfectors. Our technology offers data collection, so that consumption can be monitored, and allows the complete process to be supervised remotely, offering maximum safety, economy and eco-friendliness
Click here to download RKI-Publication 2004-JGV 85-3805-3816
Click here to download RKI Publication Journal of G.V. 2008, 89, 348-359
Click here to download RKI Publication Journal of Hospital Infection 2004 FA forte
Click here to download SMP Gutachten SeptoClean Zusammenfassung
The Collaborative Healthcare Leadership Programme |
|
20th February 2012 Faced with diminishing resource and budget, Leaders within the NHS are having... |
Pre-clinical Evaluation in Drug Development |
|
7th March 2012 The aim of this unique short course is to provide a detailed insight into the... |
Clinical Evaluation of Medical Technology |
|
13th March 2012 The course is designed to help regulatory professionals understand the fundam... |
Management of Regulatory Affairs & its Contribution to the Medical Technology Lifecycle |
|
12th June 2012 The course is designed to provide students with an understanding of the skill... |